Related Experiment Video
Updated: May 25, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Nephroprotection diabetes mellitus type 2: lessons from the ADVANCE trial]
Abstract:
Based on the results of the ADVANCE study, the article considers the issues of medication nephroprotection in patients with type 2 diabetes mellitus, including patients with uncontrolled arterial hypertension. Potentials for use of fixed combination of perindopril + indapmide, which provides therapeutic effect at all stages of renal continuum, are discussed. It is established that improved control of blood pressure by combination of perindopril + indapmide leads to a significant decrease in mortality in DM 2 patients.
Insights
Fixed combination therapy with perindopril and indapamide significantly reduces mortality in type 2 diabetes patients. This medication approach offers nephroprotection across all renal continuum stages, especially in those with uncontrolled hypertension.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Context:
- Type 2 diabetes mellitus (T2DM) poses significant risks for renal complications and cardiovascular events.
- Uncontrolled arterial hypertension exacerbates nephropathy in diabetic patients.
- The ADVANCE study provides crucial data on managing T2DM comorbidities.
Purpose:
- To evaluate the nephroprotective potential of a fixed-dose combination of perindopril and indapamide in T2DM patients.
- To assess the impact of this combination therapy on blood pressure control and overall mortality.
- To discuss the efficacy of perindopril + indapamide across the renal continuum.
Summary:
- The fixed combination of perindopril and indapamide demonstrates therapeutic benefits at all stages of the renal continuum in T2DM.
- Improved blood pressure control achieved with perindopril + indapamide significantly lowers mortality rates in T2DM patients.
- This combination therapy is highlighted for its role in medication nephroprotection for diabetic individuals, including those with hypertension.
Impact:
- The findings support the use of perindopril + indapamide for comprehensive renal protection in T2DM.
- Effective blood pressure management with this combination therapy contributes to reduced patient mortality.
- This therapeutic strategy offers a valuable option for managing complex cardiovascular and renal risks in type 2 diabetes.
Related Concept Videos
Diabetic Nephropathy
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease I: Introduction
Diabetic Retinopathy